Neoteric Technology Ltd. and Mediware Announce OEM Agreement for North America to Further Improve Blood Transfusion Management Systems

VANCOUVER, British Columbia--(BUSINESS WIRE)--Neoteric Technology Ltd. and Mediware Information Systems (Nasdaq:MEDW) announced today that they have completed an agreement under which Mediware will market Neoteric’s BloodTrack® transfusion administration and tracking components in North America and integrate these technologies into HCLL, Mediware’s next-generation blood transfusion management system. Neoteric and Mediware’s agreement will provide hospitals, clinics, correctional institutions, blood centers and other public and private health care institutions with a closed loop environment for transfusion information to increase patient safety practices, lower costs and improve efficiencies and productivity of the entire blood transfusion process.

MORE ON THIS TOPIC